Natalizumab: Perspectives from the Bench to Bedside
Author:
Publisher
Cold Spring Harbor Laboratory
Subject
General Biochemistry, Genetics and Molecular Biology
Reference65 articles.
1. Fertility, Pregnancy and Childbirth in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs
2. Transfer of Natalizumab into Breast Milk in a Mother with Multiple Sclerosis
3. Melanoma in multiple sclerosis treated with natalizumab: causal association or coincidence?
4. Erratum to: Reassessing the risk of natalizumab-associated PML;J Neurovirol,2016
5. Reassessing the risk of natalizumab-associated PML
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery;International Journal of Molecular Sciences;2022-07-29
2. Clinical trials in multiple sclerosis: past, present, and future;Neurologia i Neurochirurgia Polska;2022-06-30
3. Efficacy of Disease Modifying Therapies in Progressive MS and How Immune Senescence May Explain Their Failure;Frontiers in Neurology;2022-03-31
4. To the editors: Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England;Multiple Sclerosis and Related Disorders;2022-03
5. Natalizumab extended-interval dosing in multiple sclerosis to mitigate progressive multifocal leukoencephalopathy risk: initial study evidence and real-world experience;Journal of Central Nervous System Disease;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3